Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-20
2006-06-20
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S156000, C546S159000, C514S313000
Reexamination Certificate
active
07064134
ABSTRACT:
Compounds of formula Ias well as pharmaceutically acceptable salts and esters thereof, wherein R1, R2, R3, A1and A2have the significance given in claim1, can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.
REFERENCES:
patent: 3272824 (1966-09-01), Frederick et al.
patent: 4035367 (1977-07-01), Simpson
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 6004996 (1999-12-01), Shah et al.
patent: 185 359 (1986-06-01), None
patent: 189 577 (1986-08-01), None
patent: 443 449 (1991-08-01), None
patent: 524 495 (1993-01-01), None
patent: 882 717 (1998-12-01), None
patent: WO 99/34786 (1999-07-01), None
patent: WO 00/09122 (2000-02-01), None
patent: WO 0009123 (2000-02-01), None
patent: WO 01 23389 (2001-04-01), None
patent: WO 02 20488 (2002-03-01), None
Klug Michael G.
Mattei Patrizio
Mueller Werner
Neidhart Werner
Nettekoven Matthias Heinrich
Habte Kahsay
Hoffmann-La Roche Inc.
Johnston George W.
Remy Brian C.
Rocha-Tramaloni Patricia S.
LandOfFree
Quinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3672105